The global immunohistochemistry (IHC) market is projected to reach USD 5.14 billion by 2030, up from USD 3.55 billion in 2025, growing at a CAGR of 7.6%. For senior decision-makers in healthcare, diagnostics, and biopharma, this represents more than just incremental growth—it highlights a critical diagnostic technology reshaping oncology, pathology, and precision medicine. As favorable...